Authors' response: Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19)
- PMID: 34362637
- PMCID: PMC8238644
- DOI: 10.1016/j.numecd.2021.06.008
Authors' response: Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19)
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest.
Comment on
-
Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection.Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1613-1615. doi: 10.1016/j.dsx.2020.08.023. Epub 2020 Aug 26. Diabetes Metab Syndr. 2020. PMID: 32882643 Free PMC article.
-
Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression.Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1662-1670. doi: 10.1016/j.numecd.2021.02.020. Epub 2021 Feb 27. Nutr Metab Cardiovasc Dis. 2021. PMID: 33838992 Free PMC article.
-
Meta-analysis of statin and outcomes of coronavirus disease 2019 (COVID-19): Reconsideration is needed.Nutr Metab Cardiovasc Dis. 2021 Aug 26;31(9):2737-2739. doi: 10.1016/j.numecd.2021.06.009. Epub 2021 Jul 5. Nutr Metab Cardiovasc Dis. 2021. PMID: 34366177 Free PMC article. No abstract available.
References
-
- Bull-Otterson L., Gray E.B., Budnitz D.S., Strosnider H.M., Schieber L.Z., Courtney J. Hydroxychloroquine and chloroquine prescribing patterns by provider specialty following initial reports of potential benefit for COVID-19 treatment - United States, january-june 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 4;69(35):1210–1215. doi: 10.15585/mmwr.mm6935a4. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
